why choose us

First received: November 22, 2022

Clinical Trial: Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Primary Open Angle Glaucoma

Study Type: INTERVENTIONAL


Official Title: Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

Brief Summary: The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowering glaucoma medications are used to treat glaucoma.A total of up to 188 participants will be enrolled and randomized 1:1 to receive N&P or placebo for 87 weeks (20 months).Participants will be followed for a total of 91 weeks (21 months).

Read more